-
1
-
-
79952321958
-
Capecitabine and hand-foot syndrome
-
Saif MW: Capecitabine and hand-foot syndrome. Expert Opin Drug Saf 10: 159-169, 2011.
-
(2011)
Expert Opin Drug Saf
, vol.10
, pp. 159-169
-
-
Saif, M.W.1
-
2
-
-
0028078635
-
Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer
-
Glimelius B, Hoffman K, Graf W, Påhlman L and Sjödén PO: Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. Cancer 73: 556-562, 1994.
-
(1994)
Cancer
, vol.73
, pp. 556-562
-
-
Glimelius, B.1
Hoffman, K.2
Graf, W.3
Påhlman, L.4
Sjödén, P.O.5
-
3
-
-
1342290189
-
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study
-
Tournigand C, Andre T, Achille E, et al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22: 229-237, 2004.
-
(2004)
J Clin Oncol
, vol.22
, pp. 229-237
-
-
Tournigand, C.1
Andre, T.2
Achille, E.3
-
4
-
-
11144354462
-
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: Integrated efficacy data and novel analyses from two large, randomized, phase III trials
-
Van Cutsem E, Hoff PM, Harper P, et al: Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomized, phase III trials. Br J Cancer 90: 1190-1197, 2004.
-
(2004)
Br J Cancer
, vol.90
, pp. 1190-1197
-
-
van Cutsem, E.1
Hoff, P.M.2
Harper, P.3
-
5
-
-
73049093340
-
Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal cancer - meta-analysis of six randomized trials
-
Cao Y, Liao Y, Tan A, Liu L, Mo Z and Gao F: Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal cancer - meta-analysis of six randomized trials. Colorectal Disease 12: 16-23, 2010.
-
(2010)
Colorectal Disease
, vol.12
, pp. 16-23
-
-
Cao, Y.1
Liao, Y.2
Tan, A.3
Liu, L.4
Mo, Z.5
Gao, F.6
-
6
-
-
78649873169
-
For the GI Group of the French Anti-Cancer Centers (FNCLCC): Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
-
Ducreux M, Bennouna J, Hebbar M, Ychou M, Lledo G, Conroy T, Adenis A, Faroux R, Rebischung C, Bergougnoux L, Kockler L and Douillard J: For the GI Group of the French Anti-Cancer Centers (FNCLCC): Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer. Int J Cancer 128: 682-690, 2010.
-
(2010)
Int J Cancer
, vol.128
, pp. 682-690
-
-
Ducreux, M.1
Bennouna, J.2
Hebbar, M.3
Ychou, M.4
Lledo, G.5
Conroy, T.6
Adenis, A.7
Faroux, R.8
Rebischung, C.9
Bergougnoux, L.10
Kockler, L.11
Douillard, J.12
-
7
-
-
2942638081
-
XELOX (capecitabine plus oxaliplatin): Active first-line therapy for patients with metastatic colorectal cancer
-
Cassidy J, Tabernero J, Twelves C, et al: XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. J Clin Oncol 22: 2084-2091, 2004.
-
(2004)
J Clin Oncol
, vol.22
, pp. 2084-2091
-
-
Cassidy, J.1
Tabernero, J.2
Twelves, C.3
-
8
-
-
33646142547
-
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: The X-ACT trial
-
Cassidy J, Douillard JY, Twelves C, et al: Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial. Br J Cancer 94: 1122-1129, 2006.
-
(2006)
Br J Cancer
, vol.94
, pp. 1122-1129
-
-
Cassidy, J.1
Douillard, J.Y.2
Twelves, C.3
-
9
-
-
58049194302
-
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: A pooled analysis of randomized trials
-
Arkenau HT, Arnold D, Cassidy J, Diaz-Rubio E, Douillard JY, Hochster H, Martoni A, Grothey A, Hinke A, Schmiegel W, Schmoll HJ and Porschen R: Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials. J Clin Oncol 26: 5910-5917, 2008.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5910-5917
-
-
Arkenau, H.T.1
Arnold, D.2
Cassidy, J.3
Diaz-Rubio, E.4
Douillard, J.Y.5
Hochster, H.6
Martoni, A.7
Grothey, A.8
Hinke, A.9
Schmiegel, W.10
Schmoll, H.J.11
Porschen, R.12
-
10
-
-
42949150908
-
Randomized phase III study of capecitabine plus oxaliplatin as first-line therapy for metastatic colorectal cancer
-
Cassidy J, Clarke S, Diaz-Rubio E, et al: Randomized phase III study of capecitabine plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol 26: 2006-2012, 2008.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2006-2012
-
-
Cassidy, J.1
Clarke, S.2
Diaz-Rubio, E.3
-
11
-
-
0035503151
-
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study
-
Van Cutsem E, Twelves C, Cassidy J, et al: Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19: 4097-4106, 2001.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4097-4106
-
-
van Cutsem, E.1
Twelves, C.2
Cassidy, J.3
-
12
-
-
53049092394
-
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: A randomized phase III noninferiority study
-
Rothenberg ML, Cox JV, Butts C, Navarro M, Bang YJ, Goel R, Gollins S, Siu LL, Laguerre S and Cunningham D: Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. Annals of Oncology 19: 1720-1726, 2008.
-
(2008)
Annals of Oncology
, vol.19
, pp. 1720-1726
-
-
Rothenberg, M.L.1
Cox, J.V.2
Butts, C.3
Navarro, M.4
Bang, Y.J.5
Goel, R.6
Gollins, S.7
Siu, L.L.8
Laguerre, S.9
Cunningham, D.10
-
13
-
-
0035871538
-
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study
-
Hoff PM, Ansari R, Batist G, et al: Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19: 2282-2292, 2001.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2282-2292
-
-
Hoff, P.M.1
Ansari, R.2
Batist, G.3
-
14
-
-
84859465648
-
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy
-
Sep 6, (Epub ahead of print)
-
Twelves C, Scheithauer W, McKendrick J, Seitz JF, Van Hazel G, Wong A, Díaz-Rubio E, Gilberg F and Cassidy J: Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. Ann Oncol Sep 6, 2011 (Epub ahead of print).
-
(2011)
Ann Oncol
-
-
Twelves, C.1
Scheithauer, W.2
McKendrick, J.3
Seitz, J.F.4
van Hazel, G.5
Wong, A.6
Díaz-Rubio, E.7
Gilberg, F.8
Cassidy, J.9
|